Cited by 120Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

In vivo monoamine oxidase inhibition by d-amphetamine

Miller, Harold H., Shore, Parkhurst A., Clarke, David E.·1980·Biochemical Pharmacology

DOI 10.1016/0006-2952(80)90429-3

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0006-2952(80)90429-3

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,597
Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices
Heikkila, R. E., Orlansky, H., & Cohen, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90152-5 · Cited by 468
Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid
Roth, R. H., Murrin, L. C., & Walters, J. R. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90268-5 · Cited by 364
Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs
Neff, N. H., & Yang, H. (1974) · Life Sciences · doi:10.1016/0024-3205(74)90089-7 · Cited by 333
A COMPARISON OF THE CAPACITIES OF ISOMERS OF AMPHETAMINE, DEOXYPIPRADROL AND METHYLPHENIDATE TO INHIBIT THE UPTAKE OF TRITIATED CATECHOLAMINES INTO RAT CEREBRAL CORTEX SLICES, SYNAPTOSOMAL PREPARATIONS OF RAT CEREBRAL CORTEX, HYPOTHALAMUS AND STRIATUM AND INTO ADRENERGIC NERVES OF RABBIT AORTA
Ferris, R. M., Tang, F. L. M., & Maxwell, R. A. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29222-9 · Cited by 302
Monoamine Oxidase and its Inhibition.
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-1-123_1 · Cited by 263
Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs
Westerink, B. H. C., & Korf, J. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90331-9 · Cited by 240
Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase
Donnelly, C. H., & Murphy, D. L. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90398-7 · Cited by 238
Millennium Cohort Study: Age 17, Sweep 7, 2018
University of London, I. O. E. (2021) · VocBench (University of Rome Tor Vergata) · doi:10.5255/ukda-sn-8682-2 · Cited by 206
The effect of tropolone on the formation of 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the brain of the mouse
Murphy, G. F., Robinson, D. S., & Sharman, D. F. (1969) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1969.tb08308.x · Cited by 198
Inhibition of monoamine oxidase by amphetamine and related compounds
Mantle, T. J., Tipton, K. F., & Garrett, N. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90432-9 · Cited by 191
Effects of amphetamine on the turnover rate of brain catecholamines and motor activity
Costa, E., Groppetti, A., & Naimzada, M. K. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb07312.x · Cited by 177
Biochemical differentiation of amphetaminevsmethylphenidate and nomifensine in rats
Bræstrup, C. (1977) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1977.tb11370.x · Cited by 145
Preferential deamination of dopamine by an A type monoamine oxidase in rat brain
Waldmeier, P. C., Delini‐Stula, A., & Ma�tre, L. (1976) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00506483 · Cited by 142
Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons
Andén, N. ‐., CORRODI, H., Fuxé, K., & Ungerstedt, U. (1971) · European Journal of Pharmacology · doi:10.1016/0014-2999(71)90173-7 · Cited by 142
The influence of monoamine oxidase inhibition on catecholamine synthesis
Neff, N. H., & Costa, E. (1966) · Life Sciences · doi:10.1016/0024-3205(66)90204-9 · Cited by 139
The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation
Bræstrup, C., Andersen, H., & Randrup, A. A. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90238-1 · Cited by 126
Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron
Shore, P. A. (1976) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1976.tb04078.x · Cited by 125
Self-citation
MULTIPLE BINDING SITES OF HUMAN BRAIN AND LIVER MONOAMINE OXIDASE: SUBSTRATE SPECIFICITIES, SELECTIVE INHIBITIONS, AND ATTEMPTS TO SEPARATE ENZYME FORMS
White, H. L., & Glassman, A. T. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb06502.x · Cited by 106
THE UPTAKE AND STORAGE OF H3-NOREPINEPHRINE IN THE RESERPINE-PRETREATED RAT HEART
Iversen, L. L., Glowinski, J., & Axelrod, J. (1965) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27167-1 · Cited by 104
Benzedrine (β-phenylisopropylamine) and brain metabolism
Mann, P. J., & Quastel, J. H. (1940) · Biochemical Journal · doi:10.1042/bj0340414 · Cited by 94
Long-Term Amphetamine Treatment Decreases Brain Serotonin Metabolism: Implications for Theories of Schizophrenia
Trulson, M. E., & Jacobs, B. L. (1979) · Science · doi:10.1126/science.572992 · Cited by 90
Subcellular localization of types A and B monoamine oxidase in rat brain
Student, A. K., & Edwards, D. J. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90437-3 · Cited by 89
CHARACTERISTICS OF AMPHETAMINE-INDUCED RELEASE OF NOREPINEPHRINE FROM RAT CEREBRAL CORTEX IN VITRO
Ziance, R. J., Azzaro, A. J., & Rutledge, C. O. (1972) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29275-8 · Cited by 74
Inhibition of mouse brain monoamine oxidase by (+)-amphetaminein vivo
Green, A. L., & Hait, M. A. S. E. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13223.x · Cited by 64
Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria
Ekstedt, B. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90359-2 · Cited by 63
Dihydroxyphenylacetic acid conjugate: Natural occurrence and demonstration of probenecid-induced accumulation in rat striatum olfactory tubercles and frontal cortex
Elchisak, M. A., Maas, J. W., & Roth, R. H. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90257-6 · Cited by 46
Effects of Benzoquinolizines and Ring-Substituted Aralkylamines on Serotonin Metabolism
Pletscher, A., DAPRADA, M., Burkard, W. P., & Tranzer, J. P. (1968) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60295-1 · Cited by 28
Rat and human cardiac monoamine oxidase: A comparison with other tissues
Dial, E. J., & Clarke, D. E. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90480-1 · Cited by 20
Self-citation
Behavioral and biochemical interaction between AMT and (+)-Amphetamine: Relevance to the identification of the functional pool of brain catecholamines
Papeschi, R. (1975) · Psychopharmacology · doi:10.1007/bf00426205 · Cited by 20
Phenylethylamine—Deamination by multiple types of monoamine oxidase
Dial, E. J., & Clarke, D. E. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90148-x · Cited by 18
Self-citation
Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine
Fuller, R. W., & Snoddy, H. D. (1979) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1979.tb13468.x · Cited by 16

Research works printed but not linked: 11

Ziance, 1972, J. Pharmac. exp. Ther., 182, 284
Houslay, 1976, Life Sci., 19, 467, 10.1016/0024-3205(76)90224-1 · DOI
Callingham, 1977, Br. J. Pharmac., 61, 470P
Miller, 1978, Commun. Psychopharmac., 2, 319
Dial, 1977, Res. Commun. Chem. Path. Pharmac., 17, 145
Roffler-Tarlov, 1971, Kr. J. Pharmac., 42, 343
Demarest, 1978, Pharmacologist, 20, 217
Iverson, 1965, J. Pharmac. exp. Ther., 150, 173
Elchisak, 1976, Psychopharmac. Commun., 2, 411
Ferris, 1972, J. Pharmac. exp. Ther., 181, 407
Miller, 1977, Pharmacologist, 19, 239

Sorted by citations

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…receptor agonist to induce calcium increases and NE release in bovine adrenal chromaffin cells May et al. (1988) • AMP stimulated DA release in the caudate nucleus of rats, as measured by in vivo fast-scan cyclic voltammetry Miller et al. (1980) • AMP inhibited MAO type A activity Mukherjee…”
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626
“This is consistent with AMPH entering nerve terminals and inhibiting monoamine oxidase (MAO), one of the known actions of AMPH (Green and El Haut, 1978; Miller et al., 1980).”
Background
Amphetamine, past and present – a pharmacological and clinical perspective
Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482532 · Cited by 653
“Amphetamine’s isomers have long been known to be inhibitors of this important catabolising enzyme (Mantle et al., 1976; Miller et al., 1980; Robinson, 1985).”
Background
In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐Amphetamine
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616

See all 120

Authors: Miller, H. H., Shore, P. A., & Clarke, D. E.
Affiliations: University of Houston (US)
University of Texas Health Science Center at Dallas (US)
Corresponding author: Clarke, David E.
ORCID: Clarke, David E.
Venue: Biochemical Pharmacology
Publisher: Elsevier BV
Published: 1980-05
Volume: 29
Issue: 10
Pages: 1347-1354
ISSN: 0006-2952 (ISSN-L)
DOI: 10.1016/0006-2952(80)90429-3
OpenAlex: W2032273250
Cited by: 120
References: 32
Citations by year: 2026: 1 · 2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 3 · 2013: 2
FWCI: 2.44
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochemical Pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: d-amphetamine, L-amphetamine, monoamine oxidase inhibition, monoamine oxidase A, monoamine oxidase B, phenelzine, dopamine depletion, reserpine, cocaine, striatum
MeSH terms: Amphetamine, Animals, Brain, Cocaine, Corpus Striatum, Dextroamphetamine, Haloperidol, Male, Monoamine Oxidase Inhibitors, Phenelzine, 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-, 3,4-Dihydroxyphenylacetic Acid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

In vivo monoamine oxidase inhibition by d-amphetamine

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks